The latest news comes next year or a new round of adjustment of the base drug catalog.

According to industry sources, the relevant departments recently held a meeting on the relevant issues of the base drug, and clearly plans to update and revise the current 2015 version of the basic drug catalog management methodsin fact, as early as May, the relevant departments in 2020 work points will clearly start the adjustment of the base drug catalog in due courseIn explaining part of the basic drug system, thedocument mentions, "National Research and Evaluation of the implementation of the 2018 edition of the National Essential Medicines Directory, collection and analysis of the use of medicines at all levels of medical institutions."study and revise the national basic drug catalogue management methods, optimize the selection and adjustment procedures for the catalogue, and start the catalog adjustment work in due course"The Law of the People's Republic of China on the Promotion of Basic Health care and Health, which was officially implemented on June 1 this year, also mentions in the drug supply guarantee section that the State implements the basic drug system and dynamically adjusts the list of essential drugs in accordance with the clinical practice of drugs, changes in drug standards and new drug listingsAccording to the Opinions on Improving the National Basic Drug System issued by the General Office of the State Council on September 19, 2018, the adjustment period of the list of essential drugs shall not exceed three years in principleat the 2018 edition of the list of basic drugs, the National Health and Care Commission further said that the next step will be to implement the "Opinion" requirements, as soon as possible to revise and improve the "National Basic Drug Catalog Management Measures."as we all know, the base drug catalog management method is the guidance document for the adjustment of the base drug catalog, that is, the large probability of revising the base drug catalog management method is to pave the way for the adjustment of the new version of the base drug catalog, in accordance with the principle of dynamic adjustment of the base drug catalog 3 years one cycle, next year the base drug catalog ushered in a new round of adjustment is a big probability eventaccording to information provided by people familiar with the situation, the main points of information of the recent meeting around the base drug are as follows: 1This year will be out of the base drug management methods, in the 2015 version of the basis of the revision of 2After the introduction of the management measures will be based on the management methods to develop a specific base drug adjustment program, is not expected to start this year3The adjustment cycle of the base drug remains unchanged for 3 years and may be adjusted dynamically every year4The positioning of the base drug remains unchanged, or according to the requirements of article 88 of the base drug system, the classification of the base drug, the selection process and experts have not been specifically discussed5 No mention was made of the 1 plus x requirement 6 It is recommended that the base drug be combined with the chronic long prescription policy, and that the State design from the top level to develop a core drug catalogue of essential drugs comprehensive evaluation of clinical practice, encourage trade associations, scientific research institutions, production enterprises, medical institutions, social organizations and other active evidence-based medical research, clinical evaluation catalog management methods clear basic drug adjustment rules On August 18, 2009, the former Ministry of Health jointly 9 ministries issued the "On the establishment of the national basic drug system implementation opinion", marking China's formal implementation of the national basic drug system the second half of 2014, the former National Health and Planning Commission began to evaluate and investigate the basic drug catalogue, combined with the relevant experience of the drug catalog management method in the past five years in the medical reform, put forward some amendments, formed the 2015 version of the basic drug catalog management method According to the former Health and Planning Commission, the management method of the base medicine catalogue should become a long-term institutional arrangement, and further improve the selection mechanism of basic drugs April 14, 2015, the former State Health and Planning Commission issued a "Notice on the Administration of the Administration of the National Basic Drug Catalog", and the management measures for the catalogue of essential drugs entered the stage of the long-term system from the provisional to the date of their issuance according to the management method of the base drug catalogue at different times, the base drug catalogue in China has been adjusted three times - the most recent adjustment of the base drug catalogue is 2018 October 25, 2018, the National Health and Health Commission issued the Notice on the Issue of the National Essential Medicines Catalog (2018 Edition), with 685 varieties shortlisted, and the new version of the base drug catalogue will come into effect on November 1, 2018 in the "National Basic Drug Catalog (2018 edition) interpretation", the National Health and Health Commission specifically stressed the need to improve the catalog adjustment management mechanism, the catalog regularly carried out assessment, the implementation of dynamic adjustment, adjustment cycle in principle not more than 3 years; in accordance with the requirements of the current "National Basic Drug Catalog Management Measures", the adjustment of the base drug catalog mainly refers to the World Health Organization's basic drug catalogue and related national (regional) drug roster selection procedures and principles, in accordance with China's disease spectrum and drug use characteristics, fully consider the current basic national conditions and security capabilities, sum up the previous catalog formulation and adjustment of practical experience to clearly transfer in and out of the basic drug catalog standards the standardof drugs transferred into and transferred from the current list of basic drugs: First, combined with the alignment of disease spectrum, morbidity, disease burden, etc., to meet the common diseases, chronic diseases and heavy burden, harmful diseases and critical and severe illness, public health and other basic drug needs, from the drugs already listed in China, select the appropriate quantity of essential drugs is to support the development of Chinese medicine, support the development and innovation of the pharmaceutical industry, and tilt towards Chinese medicine (including ethnic medicine) and domestic innovation medicine the Opinions of the General Office of the State Council on Improving the National Basic Drug System also calls for strengthening evidence-based decision-making and highlighting the clinical value of medicines specification dosage form specifications, can orally doosine injection, can muscle injection does not infusion support the development of Chinese medicine and encourage research and development and innovation in the pharmaceutical industry the transfer process may be initiated in due course if the newly approved and listed drugs have significantly improved their efficacy and are reasonably priced the criteria for drug transfer: First, the drug standard was replaced; second, the State Drug Administration revoked its drug approval certificate; third, adverse reactions, assessed should not be used as a national essential drug; fourth, according to the evaluation of drug economics, can be replaced by the risk-benefit ratio or cost-effective varieties; and fifth, the National Basic Medicines Working Committee should be transferred to other circumstances in addition, the Opinions of the General Office of the State Council on the Improvement of the National Basic Drug System require that priority be brought out of the list of drugs that have been withdrawn from the market, with serious adverse reactions, which are not assessed as suitable as essential drugs, and substituted for those with risk-effective or cost-effective varieties in principle, no medicines are added to all places, and minority areas may add a small number of ethnic medicines although the management method of base medicine catalog will be further adjusted and optimized, it is undeniable that the current standard of transfer-out as stipulated in the management method of the base drug catalog still has some reference and reference significance for the adjustment of the base medicine catalog after all, since 2009, the main content of the management of the basic medicine catalog management method simply does not change greatly, it can be seen that some of these standards still stand the test of time policy has repeatedly strengthened the provision and use of basic drugs in accordance with the "State Council Office on further good job of the provision of shortage drugs to ensure stable prices" requirements, to promote the priority of the use of essential drugs and rational drug use "promote the priority use of essential drugs, enhance the proportion of basic drug use, and timely adjust the national list of basic drugs, and gradually realize the government-run primary health care institutions, secondary public hospitals, tertiary public hospitals, the proportion of basic drugs equipped with varieties in principle is not less than 90%, 80%, 60%, and promote medical institutions at all levels to form a basic drugs-led "1 plus X" ("1" for the national basic drug catalogue, "X" for non-essential drugs, by the actual determination of the use of drugs in addition, the National Health and Care Commission has requested local governments to carry out comprehensive pilot projects on the basic drug system, encourage urban medical groups and county medical communitytos to establish a unified drug catalogue and supply guarantee mechanism, and promote the convergence of drug use among medical institutions at the upper and lower levels According to Seiber Blue, many provinces have followed up the release of the 986 policy for the use of base medicine In accordance with the Opinions of the General Office of the State Council on the Improvement of the National Basic Drug System, the new version of the National Essential Medicines Catalog shall be published, and no additional drugs shall be added in principle, that is, the path to entry into the list of essential drugs from local channels has been blocked at the same time, many departments have issued a number of articles to strengthen the use of essential drugs, asking for an increase in the proportion of basic drug use based on this, a new round of national base drug catalog adjustment is undoubtedly a major industry event follow-up with the introduction of the 2020 version of the base drug catalog management measures, 2021 will be adjusted to the base drug catalog, will be further clear original title: News coming out! The base medicine catalogue will be adjusted.